{"anticipatedPostingDate":"2026-10","denomUnitsSelected":"Participants","description":"OS was defined as the time from the date of first dose until death due to any cause. If a participant was not known to have died, survival was censored at the date of last contact. Analysis was performed using Kaplan-Meier method.","reportingStatus":"NOT_POSTED","timeFrame":"Parts 1 and 2: From start of treatment to end of the study (approximately 3 years 7 months)","title":"Overall Survival (OS): Parts 1 and 2","type":"SECONDARY"}